These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19864662)

  • 1. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study.
    Pedersen KF; Alves G; Aarsland D; Larsen JP
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1279-82. PubMed ID: 19864662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apathy may herald cognitive decline and dementia in Parkinson's disease.
    Dujardin K; Sockeel P; Delliaux M; Destée A; Defebvre L
    Mov Disord; 2009 Dec; 24(16):2391-7. PubMed ID: 19908317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study.
    Pedersen KF; Alves G; Brønnick K; Aarsland D; Tysnes OB; Larsen JP
    J Neurol; 2010 Feb; 257(2):217-23. PubMed ID: 19705051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociating apathy and depression in Parkinson disease.
    Kirsch-Darrow L; Fernandez HH; Marsiske M; Okun MS; Bowers D
    Neurology; 2006 Jul; 67(1):33-8. PubMed ID: 16832074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apathy in Parkinson's disease: A systematic review and meta-analysis.
    den Brok MG; van Dalen JW; van Gool WA; Moll van Charante EP; de Bie RM; Richard E
    Mov Disord; 2015 May; 30(6):759-69. PubMed ID: 25787145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apathy in untreated early-stage Parkinson disease: relationship with other non-motor symptoms.
    Dujardin K; Langlois C; Plomhause L; Carette AS; Delliaux M; Duhamel A; Defebvre L
    Mov Disord; 2014 Dec; 29(14):1796-801. PubMed ID: 25370724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caregiver report of apathy predicts dementia in Parkinson's disease.
    Fitts W; Weintraub D; Massimo L; Chahine L; Chen-Plotkin A; Duda JE; Hurtig HI; Rick J; Trojanowski JQ; Dahodwala N
    Parkinsonism Relat Disord; 2015 Aug; 21(8):992-5. PubMed ID: 26117435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of dementia in Parkinson's disease: a community-based, prospective study.
    Aarsland D; Andersen K; Larsen JP; Lolk A; Nielsen H; Kragh-Sørensen P
    Neurology; 2001 Mar; 56(6):730-6. PubMed ID: 11274306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of psychiatric symptoms and global cognition in early Parkinson disease.
    de la Riva P; Smith K; Xie SX; Weintraub D
    Neurology; 2014 Sep; 83(12):1096-103. PubMed ID: 25128183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline predictors of worsening apathy in Parkinson's disease: A prospective longitudinal study.
    Wee N; Kandiah N; Acharyya S; Chander RJ; Ng A; Au WL; Tan LC
    Parkinsonism Relat Disord; 2016 Feb; 23():95-8. PubMed ID: 26705846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Apathy in Parkinson's disease. Impairment in quality of life].
    Bottini Bonfanti A; Etcheverry JL; Persi GG; Zezza H; Starkstein S; Gatto EM
    Medicina (B Aires); 2009; 69(2):253-8. PubMed ID: 19435698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective longitudinal study of apathy in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):8-11. PubMed ID: 16361584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apathy and depression in Parkinson's disease: the Belgrade PD study report.
    Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS
    Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathophysiological mechanisms of motivational deficits in Parkinson's disease.
    Chagraoui A; Boukhzar L; Thibaut F; Anouar Y; Maltête D
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():138-152. PubMed ID: 29097256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.